| Literature DB >> 23710228 |
Bruno Alves Rocha1, Paula Carolina Pires Bueno, Mirela Mara de Oliveira Lima Leite Vaz, Andresa Piacezzi Nascimento, Nathália Ursoli Ferreira, Gabriela de Padua Moreno, Marina Rezende Rodrigues, Ana Rita de Mello Costa-Machado, Edna Aparecida Barizon, Jacqueline Costa Lima Campos, Pollyanna Francielli de Oliveira, Nathália de Oliveira Acésio, Sabrina de Paula Lima Martins, Denise Crispim Tavares, Andresa Aparecida Berretta.
Abstract
Since the beginning of propolis research, several groups have studied its antibacterial, antifungal, and antiviral properties. However, most of these studies have only employed propolis ethanolic extract (PEE) leading to little knowledge about the biological activities of propolis water extract (PWE). Based on this, in a previous study, we demonstrated the anti-inflammatory and immunomodulatory activities of PWE. In order to better understand the equilibrium between effectiveness and toxicity, which is essential for a new medicine, the characteristics of PWE were analyzed. We developed and validated an RP-HPLC method to chemically characterize PWE and PEE and evaluated the in vitro antioxidant/antimicrobial activity for both extracts and the safety of PWE via determining genotoxic potential using in vitro and in vivo mammalian micronucleus assays. We have concluded that the proposed analytical methodology was reliable, and both extracts showed similar chemical composition. The extracts presented antioxidant and antimicrobial effects, while PWE demonstrated higher antioxidant activity and more efficacious for the most of the microorganisms tested than PEE. Finally, PWE was shown to be safe using micronucleus assays.Entities:
Year: 2013 PMID: 23710228 PMCID: PMC3655582 DOI: 10.1155/2013/670451
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Concentration range for the calibration curves of the five phenolic compounds used in this study.
| Chemical marker | Concentration range in | |||||||
|---|---|---|---|---|---|---|---|---|
| Caffeic acid | 1.06 | 2.12 | 4.24 | 6.36 | 8.48 | 10.60 | 12.72 | 16.96 |
|
| 5.04 | 10.08 | 20.16 | 30.24 | 40.32 | 50.40 | 60.48 | 80.64 |
|
| 0.40 | 0.80 | 1.60 | 2.40 | 3.20 | 4.00 | 4.80 | 6.40 |
| Aromadendrin | 2.00 | 4.00 | 8.00 | 12.00 | 16.00 | 20.00 | 24.00 | 32.00 |
| Artepillin C | 10.06 | 20.12 | 40.24 | 60.36 | 80.48 | 100.60 | 120.72 | 160.96 |
Figure 1Chromatographic profiles of the five phenolic compounds (a) including the internal standard gallic acid: (1) internal standard; (2) caffeic acid; (3) p-coumaric acid; (4) cinnamic acid; (5) aromadendrin, and (6) artepillin C; (b) propolis water extract, and finally, (c) propolis ethanolic extract.
Results of linearity, quantitation, and detection limits determined for the five phenolic compounds used in this study.
| Chemical marker | Regression curve |
| LOD | LOQ |
|---|---|---|---|---|
| Caffeic acid |
| 0.9991 | 0.39 | 1.51 |
|
|
| 0.9993 | 0.21 | 0.81 |
|
|
| 0.9993 | 0.10 | 0.40 |
| Aromadendrin |
| 0.9992 | 0.52 | 2.00 |
| Artepillin C |
| 0.9992 | 0.50 | 1.93 |
Precision results for propolis water extract (PWE) and propolis ethanolic extract (PEE).
| Sample | Chemical marker | Intraday repeatability ( | Interday repeatability ( |
| ||||
|---|---|---|---|---|---|---|---|---|
| Average quantity | RSD | VAR | Average quantity | RSD | VAR | |||
| Caffeic acid | 0.342 | 8.25 | 0.00080 | 0.362 | 6.44 | 0.00054 | 0.68 | |
|
| 1.078 | 0.44 | 0.00002 | 1.075 | 1.00 | 0.00012 | 5.08 | |
| PWE |
| 0.078 | 2.18 | 0.00000 | 0.077 | 0.61 | 0.00000 | 0.50 |
| Aromadendrin | 0.097 | 3.38 | 0.00001 | 0.097 | 2.48 | 0.00001 | 1.88 | |
| Artepillin C | 4.393 | 1.98 | 0.00758 | 5.450 | 1.43 | 0.00603 | 1.26 | |
|
| ||||||||
| Caffeic acid | 0.267 | 1.48 | 0.00002 | 0.276 | 0.36 | 0.00000 | 0.06 | |
|
| 1.418 | 0.72 | 0.00010 | 1.433 | 0.46 | 0.00004 | 0.42 | |
| PEE |
| 0.160 | 2.84 | 0.00002 | 0.152 | 0.91 | 0.00000 | 0.16 |
| Aromadendrin | 0.772 | 0.97 | 0.00006 | 0.810 | 1.38 | 0.00013 | 0.45 | |
| Artepillin C | 5.480 | 3.01 | 0.02727 | 5.135 | 1.77 | 0.00828 | 3.29 | |
RSD: relative standard deviation.
VAR: variance.
Figure 2Phenolic and flavonoids contents of PEE and PWE presentation. (a) Total phenolic compounds like gallic acid equivalents (mg/mL) (n = 3). (b) Total flavonoids compounds expressed like quercetin equivalents (mg/mL) (n = 3). *P < 0.05 (unpaired Student t-test, α = 0.05).
The concentration of propolis water (PWE) or ethanolic (PEE) extracts, from Brazilian green propolis, required for a 50% reduction of DPPH or Fe3+, representing free radical scavenging and ferric reducing activity, respectively.
| Extract | DPPH• scavening | Fe3+-Fe2+ Reducing | ||
|---|---|---|---|---|
| IC50 |
| IC50 |
| |
| PEE | 56.71 ± 2.31 | 0.9964 | 282 ± 9.4 | 0.9971 |
| PWE | 33.36 ± 2.22 | 0.9988 | 270 ± 3.27 | 0.9925 |
Values are mean ± SD obtained from analyses in triplicate.
The values were expressed as μg/mL. Lower IC50 values indicate higher antioxidant activity.
Minimum bactericidal concentration (MBC) of propolis water extract (PWE) and propolis ethanolic extract (PEE) from Brazilian green propolis.
| Microorganisms | MBCa ( | |
|---|---|---|
| PEE | PWE | |
|
| 346.25 ± 0.012* | 136.67 ± 0.003 |
|
| 173.13 ± 0.006* | 68.33 ± 0.002 |
|
| 346.25 ± 0.012* | 136.67 ± 0.003 |
|
| 43.28 ± 0.002 | 136.67 ± 0.003* |
|
| 692.5 ± 0.024 | 1093.3 ± 0.023* |
|
| 43.28 ± 0.002* | 17.03 ± 0.000 |
aMBC values (μg/mL) expressed like total flavonoid content. *Significant difference between PEE and PWE (P < 0.001).
Values are presented as the mean ± SD (n = 3).
Figure 3Percentages of viable V79 cells after exposure to different concentrations (μg/mL) of propolis water extract for 24 h, determined by the XTT colorimetric assay. (*) P < 0.05.
Frequency of nuclear division (NDI), micronucleated binucleated cells (MNCBNs), and micronucleated polychromatic erythrocytes (MNPCEs) after treatment with different concentrations of propolis water extract and their respective controls.
|
| ||
|---|---|---|
| Treatments ( | NDIa | MNCBNsb |
| Negative control | 1.75 ± 0.05 | 6.33 ± 0.57 |
| 6.25 | 1.80 ± 0.03 | 4.33 ± 1.52 |
| 12.5 | 1.76 ± 0.06 | 4.34 ± 0.57 |
| 25.0 | 1.80 ± 0.02 | 7.66 ± 0.57 |
| MMS | 1.75 ± 0.06 | 57.60 ± 11.9* |
|
| ||
|
| ||
| Treatments (mg/kg b.w.) | NDIc | MNPCEsd |
|
| ||
| Negative control | 0.68 ± 0.01 | 3.0 ± 0.0 |
| 7 | 0.65 ± 0.04 | 4.0 ± 2.0 |
| 14 | 0.68 ± 0.03 | 4.6 ± 2.0 |
| 21 | 0.60 ± 0.04 | 4.8 ± 1.6 |
| CPA | 0.61 ± 0.02 | 50.6 ± 7.0* |
MMS: methyl methanesulfonate (44 μg/mL); CPA: cyclophosphamide (50 mg/kg b.w.). a500 binucleated cells were analysed per culture, corresponding to a total of 1500 cells per treatment. b1000 binucleated cells were counted per culture, corresponding to a total of 3000 cells per treatment. c400 erythrocytes were analysed per animal, corresponding to a total of 2400 cells per treatment. d2000 erythrocytes were analysed per animal, corresponding to a total of 12,000 cells per treatment.
The values are presented as the mean ± standard deviation.
*Significantly different from the negative control group (P < 0.05).
Mean values for the initial and final weight, weight gained, and water consumption obtained from Swiss mice treated with propolis water extract for 7 days and respective controls. The values are presented as the mean ± standard deviation.
| Treatments | Initial weight | Final weight | Weight gain | Water consumption |
|---|---|---|---|---|
| Negative control | 21.25 ± 3.18 | 23.00 ± 3.53 | 1.75 ± 0.35 | 4.64 ± 3.66 |
| 7 | 30.08 ± 0.49 | 30.75 ± 0.82 | 0.67 ± 0.52 | 4.17 ± 2.26 |
| 14 | 23.58 ± 1.88 | 28.67 ± 1.12 | 5.08 ± 2.15 | 9.59 ± 3.53 |
| 21 | 28.25 ± 1.72 | 29.50 ± 2.37 | 1.25 ± 1.08 | 9.97 ± 4.26 |
| CPA | 25.25 ± 2.81 | 27.33 ± 2.25 | 2.08 ± 0.74 | 3.81 ± 2.72 |
CPA: cyclophosphamide (50 mg/kg b.w.).